MobQoL: Outcome measure pilot

  • Research type

    Research Study

  • Full title

    Mobility and Quality of Life: Piloting a patient reported outcome measure for mobility-related quality of life

  • IRAS ID

    274745

  • Contact name

    Nathan Bray

  • Contact email

    n.bray@bangor.ac.uk

  • Sponsor organisation

    Bangor University

  • Duration of Study in the UK

    1 years, 0 months, 0 days

  • Research summary

    Mobility impairment is the most common cause of disability in the UK. The NHS provides millions of people with mobility-enhancing treatments, devices and therapies every year. However, more evidence is needed to understand how cost-effective these different interventions are.

    The NHS has a limited amount of money for different treatments, so evidence is needed to help decide which treatments to prioritise. One way to do this is to measure cost-effectiveness. In order to do so we need to understand the costs of different treatments, and the benefits they provide.

    Because different treatments have different purposes and benefits for patients, it is often difficult to compare cost-effectiveness results between different treatments. In order make it easier to compare the cost-effectiveness of different treatments, the outcome measures we use to measure health benefits need to be easier to compare. Outcome measures are usually short questionnaire surveys which ask patients about their health and quality of life before they receive a new treatment, and again afterwards. This information can be used to understand the treatment benefits for patients.

    Lots of different outcome measures exist at the moment, but very few focus specifically on mobility impairment. For this reason, in a previous study we developed the first outcome measure focused on the impact of mobility impairment on health and quality of life. We called this outcome measure MobQoL.

    The aim of this new study is to test how reliable and sensitive the MobQoL outcome measure is. We aim to do this by asking patients to complete the MobQoL outcome measure and some other pre-existing outcomes measures. We will then analyse the results to find out if MobQoL is a good way to measure the benefits of different treatments, devices and therapies for people with impaired mobility.

  • REC name

    South Central - Hampshire A Research Ethics Committee

  • REC reference

    19/SC/0659

  • Date of REC Opinion

    16 Jan 2020

  • REC opinion

    Further Information Favourable Opinion